Cohen & Grigsby Counsels Bayer HealthCare on Sale of Interventional Device Business
On Friday, August 29 Cohen & Grigsby worked with client Bayer HealthCare to complete the company’s sale of its thrombectomy and atherectomy medical device businesses to Boston Scientific Corporation for $415 million. With this sale, Bayer HealthCare’s Medical Care division can concentrate on innovation and growth in Radiology and Diabetes Care, where the business already has a strong presence. Learn more about the sale here.
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.